Neuraxpharm to launch its first probiotic product in Europe

This article was originally published here

Neuraxpharm has entered into an exclusive licensing agreement with the probiotics company Bened Biomedical, under which Neuraxpharm secured exclusive rights to market its first probiotic lactobacillus plantarum PS128

The post Neuraxpharm to launch its first probiotic product in Europe appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply